How Does Cholesterol Affect Cardiovascular Risk and What Are the Evidence-Based Targets?

The short answer

LDL cholesterol is causally linked to atherosclerosis and cardiovascular disease through Mendelian randomisation studies, genetic evidence, and over 30 statin RCTs. Each 1 mmol/L (approximately 39 mg/dL) reduction in LDL reduces major cardiovascular events by 22%. There is no lower threshold below which LDL reduction ceases to be beneficial — lower LDL is consistently associated with lower risk.

What the evidence actually shows

The Cholesterol Treatment Trialists' (CTT) Collaboration (2010) in The Lancet pooled individual patient data from 21 statin trials involving 129,526 participants. Each 1 mmol/L reduction in LDL cholesterol reduced major vascular events by 22%, with consistent effects across all patient subgroups. Ference et al. (2017) used Mendelian randomisation — a method that exploits naturally occurring genetic variants to establish causality — to demonstrate that the cardiovascular benefit of LDL reduction is proportional to both the magnitude and duration of exposure, and that lifelong lower LDL (from birth) provides far greater benefit than late-life pharmacological reduction. MedlinePlus notes that high LDL cholesterol is a major risk factor for heart disease and stroke.

"Each 1 mmol/L reduction in LDL cholesterol produced a 22% reduction in major vascular events, with consistent effects across all patient groups."

— CTT Collaboration, The Lancet 2010

What the major health authorities say

MedlinePlus and the NIH recommend regular cholesterol testing starting at age 20, with more frequent testing for those with risk factors. The 2019 ACC/AHA guidelines recommend lifestyle modification (diet, exercise, weight loss) as the first-line intervention for elevated LDL, with statin therapy for individuals at high cardiovascular risk. The NIA recommends a heart-healthy diet low in saturated and trans fats, regular physical activity, and maintaining a healthy weight as the primary strategies for cholesterol management.

Practical implications

Dietary changes that reduce LDL cholesterol include: replacing saturated fats (butter, full-fat dairy, fatty meat) with unsaturated fats (olive oil, nuts, avocado); increasing soluble fibre intake (oats, legumes, psyllium); and reducing trans fats (partially hydrogenated oils in processed foods). These changes can reduce LDL by 10–20%. Regular aerobic exercise raises HDL cholesterol and reduces triglycerides. For individuals at high cardiovascular risk, statins are among the most evidence-supported medications available, with a well-characterised safety profile.

Where reasonable people still disagree

• The appropriate LDL target for primary prevention in individuals without established cardiovascular disease — whether aggressive lowering to <1.4 mmol/L is warranted for all high-risk individuals.
• The clinical significance of HDL cholesterol — while low HDL is associated with cardiovascular risk, raising HDL pharmacologically has not consistently reduced events in RCTs.
• The role of lipoprotein(a) as an independent cardiovascular risk factor and whether it should be measured routinely.